Jeong Ok Lim – författare

3D Bioprinting and Bioinks for Regenerative Engineering: Current Concepts and Future Advances is a comprehensive resource dedicated to bioinks, covering materials, design formulations, biological interactions, commercial products, and their diverse applications in regenerative engineering of various tissues and organs. The table of contents outlines a comprehensive structure exploring the field of 3D bioprinting. Part I serves as an introduction, laying the foundation for the concepts and significance of this emerging technology. Part II delves into the various 3D printing technologies that enable the creation of complex biological structures. Part III focuses on the fundamentals of bioinks-critical materials that play a key role in printing viable tissues. In Part IV, attention shifts to the actual process of printing and the development of tissue and organ constructs, highlighting practical applications and advancements. Finally, Part V addresses the regulatory considerations and offers insights into future perspectives, emphasizing the challenges and opportunities ahead as the field continues to evolve. As the field is on the verge of a new era in engineering tissues, and tissue/body on a chip technologies where bioinks will play a central role. Bioinks have also become a multidisciplinary field involving materials science, cell biology, biofabrication, and clinical applications. "3D Bioprinting and Bioinks for Regenerative Engineering" will serve as a unifying resource for students, trainees, and professionals across these disciplines, offering insights into the future of regenerative medicine. By combining cutting-edge research, practical applications, and expert contributions, this book will become an indispensable resource for both newcomers and experienced professionals.Focuses exclusively on bioinks for tissue printing and regenerative medicineIncludes tissue/body on a chip technologiesContains real-world case studies and examples of how bioinks are transforming clinical practice, drug development, and personalized medicine